# atrial (audio feeds) — RSS Amplifier

Recent posts from the 1 feeds in the RSS Amplifier directory that cover atrial.

Page: <https://rssamplifier.com/topics/atrial/audio>  
Feed: <https://rssamplifier.com/topics/atrial/audio.md>

---

## [The PRAGUE-25 Study](https://soundcloud.com/user-842180102-237361060/the-prague-25-study)

_2026-08-05 · Talking Points_

Pavel Osmancik and C. Michael Gibson discuss whether catheter ablation is superior to risk factor modification with antiarrythmic drugs for the treatment of AF.

[Listen](https://feeds.soundcloud.com/stream/2374390502-user-842180102-237361060-the-prague-25-study.mp3)

## [The BETAMI-DANBLOCK Trial](https://soundcloud.com/user-842180102-237361060/the-betami-danblock-trial)

_2026-07-22 · Talking Points_

How does discontinuing beta-blockers after MI affect outcomes in patients without HF? Dan Atar and C. Michael Gibson break it down.

[Listen](https://feeds.soundcloud.com/stream/2365790798-user-842180102-237361060-the-betami-danblock-trial.mp3)

## [New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI](https://soundcloud.com/user-842180102-237361060/new-york-valves-2026)

_2026-07-01 · Talking Points_

In one of the most thought-provoking sessions at New York Valves 2026, Michael Mack and Roxana Mehran moderate a panel discussion looking at the future of TAVI from all angles.

[Listen](https://feeds.soundcloud.com/stream/2351259170-user-842180102-237361060-new-york-valves-2026.mp3)

## [The PROCTOR Trial](https://soundcloud.com/user-842180102-237361060/the-proctor-trial)

_2026-06-03 · Talking Points_

Ruben de Winter and C. Michael Gibson compare clinical outcomes of native vessel versus SVG PCI for patients with prior CABG.

[Listen](https://feeds.soundcloud.com/stream/2331408467-user-842180102-237361060-the-proctor-trial.mp3)

## [The SELUTION DeNovo Trial](https://soundcloud.com/user-842180102-237361060/the-selution-denovo-trial)

_2026-05-20 · Talking Points_

Christian M. Spaulding and C. Michael Gibson look at the 1-year results from the study comparing sirolimus-eluting DCB with DES for de novo coronary lesions.

[Listen](https://feeds.soundcloud.com/stream/2323673777-user-842180102-237361060-the-selution-denovo-trial.mp3)

## [The VESALIUS-CV Trial](https://soundcloud.com/user-842180102-237361060/the-vesalius-cv-trial)

_2026-05-06 · Talking Points_

Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.

[Listen](https://feeds.soundcloud.com/stream/2315247023-user-842180102-237361060-the-vesalius-cv-trial.mp3)

## [The META-AF Trial](https://soundcloud.com/user-842180102-237361060/the-meta-af-trial)

_2026-04-22 · Talking Points_

Amrish Deshmukh talks to C. Michael Gibson about the use of metformin as an adjunctive therapy to catheter ablation of AF.

[Listen](https://feeds.soundcloud.com/stream/2306674529-user-842180102-237361060-the-meta-af-trial.mp3)

## [Evolution of Pharmacotherapy in STEMI](https://soundcloud.com/user-842180102-237361060/evolution-of-pharmacotherapy)

_2026-04-01 · Talking Points_

How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.

[Listen](https://feeds.soundcloud.com/stream/2294760290-user-842180102-237361060-evolution-of-pharmacotherapy.mp3)

## [The CorCMR Trial](https://soundcloud.com/user-842180102-237361060/the-corcmr-trial)

_2026-03-04 · Talking Points_

Colin Berry and C. Michael Gibson discuss whether stress CMR imaging is helpful in patients with angina and no obstructive CAD.

[Listen](https://feeds.soundcloud.com/stream/2276094743-user-842180102-237361060-the-corcmr-trial.mp3)

## [Finnish Seedboxes — Up to 20Gbps (Sponsored)](https://crawlproof.com/a/tfY9wgINpg6s)

_2026-03-04 · **Sponsored**_

Private Finnish seedboxes with 1–20Gbps speeds, RAID storage and 14‑day refund

## [The TUXEDO-2 Trial](https://soundcloud.com/user-842180102-237361060/the-tuxedo-2-trial)

_2026-02-04 · Talking Points_

Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.

[Listen](https://feeds.soundcloud.com/stream/2260011032-user-842180102-237361060-the-tuxedo-2-trial.mp3)

